Ube, Japan

Akira Takama


 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2000-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Akira Takama: Innovator in Pharmaceutical Chemistry

Introduction

Akira Takama is a notable inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 5 patents, his work has garnered attention for its innovative approaches and potential benefits in medicine.

Latest Patents

One of Takama's latest patents is focused on a crystal of salt of a novel 3-azabicyclo[3.1.0]hexane derivative. This compound exhibits μ-opioid receptor antagonistic action, characterized by few side effects and high safety. The crystal boasts high purity and excellent physical properties, including stability and solubility. Another significant patent involves an indazole derivative or its salt, which has shown excellent antioxidation action in a microsome lipid peroxidation measuring system using rat liver microsomes. This compound is useful as an antioxidant, highlighting its potential for pharmaceutical applications.

Career Highlights

Throughout his career, Akira Takama has worked with prominent companies such as Ube Industries, Inc. and Chugai Seiyaku Kabushiki Kaisha. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical chemistry.

Collaborations

Takama has collaborated with notable coworkers, including Kikuo Ataka and Hiroyuki Miyata. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.

Conclusion

Akira Takama's contributions to pharmaceutical chemistry through his innovative patents and collaborations underscore his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical science and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…